ArticleInternal medicine journal2026
Practical recommendations for treating patients with chronic kidney disease in Australia: a multidisciplinary approach.
Article in Internal medicine journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundChronic kidney disease (CKD) is a significant public health challenge in Australia, affecting ~10% of the adult population and contributing to substantial morbidity and mortality. Diabetes, hypertension, cardiovascular disease and CKD frequently co-exist; therefore, a multidisciplinary approach is necessary to manage these conditions. Recent advances in pharmacological therapies, particularly for diabetic kidney disease (DKD), can improve clinical outcomes. Current guidelines may not fully address the complexities of CKD management across all levels of care in the Australian context.
objectiveTo develop simple, practical, evidence-based recommendations to guide healthcare practitioners in improving CKD management across Australia.
methodsA multidisciplinary panel of eight healthcare practitioners (nephrologists, cardiologists, endocrinologists and general practitioners) employed an adapted virtual nominal group technique to achieve consensus on CKD management recommendations.
resultsThe panel developed nine unique recommendations; five achieved consensus, and four were in accordance with GRADE guidance: Both urine albumin-to-creatinine ratio (uACR) and estimated glomerular filtration rate (eGFR) should be assessed regularly in patients at increased CKD risk. Most patients with CKD can be managed in primary care, with specialist referral when required. Ensure all cardiometabolic risk factors are assessed and managed proactively. For patients with diabetic kidney disease, consider the four pillars of therapy.
conclusionThese multidisciplinary consensus recommendations provide actionable guidance for Australian healthcare practitioners to improve CKD management across all levels of care, addressing the unique needs of the Australian healthcare landscape.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.